HRMY - CIK 0001802665
The table below shows Harmony Biosciences Holdings, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $589.40M | $647.00M | $546.05M | $489.00M | $387.37M | $317.30M |
| Short-term investments | $51.52M | $25.58M | $19.22M | $17.95M | $23.11M | $29.61M |
| Receivables | $108.22M | $100.65M | $92.98M | $105.97M | $81.50M | $83.16M |
| Inventory | $5.28M | $6.88M | $6.10M | $6.38M | $6.92M | $5.64M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $778.82M |
| $838.80M |
| $691.35M |
| $642.69M |
| $522.40M |
| $458.34M |
| Property, plant & equipment | - | $1.44M | $1.38M | $1.38M | $750.00K | $754.00K |
| Goodwill | - | - | - | - | - | - |
| Total assets | $1.27B | $1.21B | $1.11B | $1.06B | $928.13M | $858.38M |
| Accounts payable | $28.60M | $26.34M | $28.30M | $17.46M | $10.53M | $22.68M |
| Total current liabilities | $217.34M | $223.40M | $180.13M | $175.12M | $161.28M | $146.58M |
| Long-term debt | $138.81M | $148.51M | $153.34M | $158.18M | $167.85M | $171.42M |
| Total liabilities | $361.48M | $373.10M | $334.93M | $335.01M | $331.33M | $319.80M |
| Retained earnings | $193.39M | $138.42M | $87.55M | $47.78M | -$47.26M | -$93.35M |
| Total equity | $910.35M | $835.12M | $773.08M | $720.52M | $596.80M | $538.58M |